Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Nordic Life Science Insight's Logo
2017
April
May
June
July
August
September
October
November
December
Select month
20182019

2017

-

August

Date
Title
Category
Company
August 7, 2017
Read all the key arguments in favor of relocating ema to copenhagen and medicon valley
Life Science
Medicon Valley Alliance
August 7, 2017
Funding Innovation in BioPharma and IT
Life Science
Oslo Cancer Cluster
August 7, 2017
Doing More in Prognosis and Diagnosis
Life Science
Oslo Cancer Cluster
August 9, 2017
Having Chemistry with Chemistry
Life Science
Oslo Cancer Cluster
August 10, 2017
InDex Pharmaceuticals receives orphan-drug designation for pediatric ulcerative colitis in the US
Pharma
InDex Pharmaceuticals
August 16, 2017
Persontilpasset medisin i Arendal
Life Science
Oslo Cancer Cluster
August 22, 2017
Sweden – the top candidate for EMA
Life Science
SwedenBIO
August 28, 2017
Victoza® (liraglutide) is approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of three major adverse cardiovascular events
Pharma
Novo Nordisk Pharmatech A/S
August 29, 2017
InDex Pharmaceuticals Holding AB (publ) interim report January – June 2017
Pharma
InDex Pharmaceuticals
August 31, 2017
Professor Carl Borrebaeck awarded with the BiotechBuilders Award 2017
Biotech
Medicon Valley Alliance

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
LinkedIn icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2019